• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用行政和医疗记录数据对老年女性乳腺癌患者的合并症进行测量。

Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data.

作者信息

Newschaffer C J, Bush T L, Penberthy L T

机构信息

Saint Louis University School of Public Health, Department of Community Health, Missouri 63108, USA.

出版信息

J Clin Epidemiol. 1997 Jun;50(6):725-33. doi: 10.1016/s0895-4356(97)00050-4.

DOI:10.1016/s0895-4356(97)00050-4
PMID:9250271
Abstract

The inter-rater reliability, cross-source (Medicare claims versus medical record) agreement, and ability to predict all-cause mortality of three aggregate comorbidity indices were evaluated in a group of 404 elderly, incident breast cancer cases identified from the Virginia Cancer Registry and linked to Medicare administrative data files. Comorbidity was based on both medical records and Medicare claims data using indices from Charlson et al (1987), Satariano and Ragland (1994), and Kaplan and Feinstein (1974). Inter-rater agreement was good for all indices (kappas > or = 0.80). Agreement between comorbidity indices measured by claims and medical records was considerably poorer (kappas between 0.30 and 0.40). However, claims-based and medical records-based comorbidity indices were similarly associated with mortality. For the Charlson index, the index best predicting survival, the adjusted relative risk for an increase from a lower to higher comorbidity category was 1.48 (95% confidence interval 1.23, 1.78) based on medical records compared to 1.53 (95% confidence interval 1.23, 1.93) based on Medicare claims. The claims-based Charlson index score still appeared to be associated with survival (relative risk = 1.30; 95% confidence interval = 1.00, 1.70) after controlling for the medical records-based score. This suggests that both comorbidity data sources add valuable prognostic information and, conversely, that the use of either source alone will result in some misclassification of comorbidity.

摘要

在一组从弗吉尼亚癌症登记处识别出并与医疗保险管理数据文件相链接的404例老年初发乳腺癌病例中,对三种综合合并症指数的评分者间信度、跨来源(医疗保险理赔数据与病历)一致性以及预测全因死亡率的能力进行了评估。合并症基于病历和医疗保险理赔数据,采用了Charlson等人(1987年)、Satariano和Ragland(1994年)以及Kaplan和Feinstein(1974年)的指数。所有指数的评分者间一致性良好(卡帕值≥0.80)。通过理赔数据和病历测量的合并症指数之间的一致性要差得多(卡帕值在0.30至0.40之间)。然而,基于理赔数据和基于病历的合并症指数与死亡率的关联相似。对于预测生存情况最佳的Charlson指数,基于病历,从较低合并症类别增加到较高合并症类别的调整后相对风险为1.48(95%置信区间1.23,1.78),而基于医疗保险理赔数据的为1.53(95%置信区间1.23,1.93)。在控制了基于病历的评分后,基于理赔数据的Charlson指数评分似乎仍与生存相关(相对风险 = 1.30;95%置信区间 = 1.00,1.70)。这表明两种合并症数据来源都增加了有价值的预后信息,相反,单独使用任何一种来源都会导致合并症的一些错误分类。

相似文献

1
Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data.利用行政和医疗记录数据对老年女性乳腺癌患者的合并症进行测量。
J Clin Epidemiol. 1997 Jun;50(6):725-33. doi: 10.1016/s0895-4356(97)00050-4.
2
The performance of different lookback periods and sources of information for Charlson comorbidity adjustment in Medicare claims.医疗保险理赔中不同回顾期及Charlson合并症调整信息来源的表现。
Med Care. 1999 Nov;37(11):1128-39. doi: 10.1097/00005650-199911000-00005.
3
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.一种用于乳腺癌、前列腺癌、结直肠癌和肺癌患者基于索赔研究的精细化共病测量算法。
Ann Epidemiol. 2007 Aug;17(8):584-90. doi: 10.1016/j.annepidem.2007.03.011. Epub 2007 May 25.
4
A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer.一种基于多种合并症预测生存的综合预后指数:以乳腺癌为重点。
Med Care. 1999 Jun;37(6):601-14. doi: 10.1097/00005650-199906000-00009.
5
Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.国家癌症数据库与监测、流行病学和最终结果-医疗保险数据库中合并症的比较。
Ann Surg Oncol. 2016 Dec;23(13):4139-4148. doi: 10.1245/s10434-016-5508-5. Epub 2016 Aug 17.
6
Strategies for improving comorbidity measures based on Medicare and Medicaid claims data.基于医疗保险和医疗补助索赔数据改进共病测量的策略。
J Clin Epidemiol. 2000 Jun;53(6):571-8. doi: 10.1016/s0895-4356(00)00222-5.
7
Comparing a medical records-based and a claims-based index for measuring comorbidity in patients with lung or colon cancer.比较基于病历和基于理赔记录的指数在衡量肺癌或结肠癌患者共病情况中的应用。
J Geriatr Oncol. 2015 May;6(3):202-10. doi: 10.1016/j.jgo.2015.01.005. Epub 2015 Feb 3.
8
Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients.乳腺癌患者中基于访谈和基于病历的合并症指数比较。
Med Care. 1999 Apr;37(4):339-49. doi: 10.1097/00005650-199904000-00004.
9
Comorbidity indices to predict mortality from Medicare data: results from the national registry of atrial fibrillation.利用医疗保险数据预测死亡率的共病指数:来自全国心房颤动登记处的结果。
Med Care. 2005 Nov;43(11):1073-7. doi: 10.1097/01.mlr.0000182477.29129.86.
10
Development of a comorbidity index using physician claims data.利用医生申报数据开发一种共病指数。
J Clin Epidemiol. 2000 Dec;53(12):1258-67. doi: 10.1016/s0895-4356(00)00256-0.

引用本文的文献

1
Assessing Trends in Hospitalizations for Breast Cancer among Women in Korea: A Utilization of the Korea National Hospital Discharge In-depth Injury Survey (2006-2020).评估韩国女性乳腺癌住院治疗趋势:利用韩国国家医院出院深度伤害调查(2006 - 2020年)
J Epidemiol Glob Health. 2024 Jun;14(2):411-419. doi: 10.1007/s44197-024-00229-1. Epub 2024 Apr 29.
2
The Impact of Frailty Screening on Radiation Treatment Modification.衰弱筛查对放疗方案调整的影响
Cancers (Basel). 2022 Feb 21;14(4):1072. doi: 10.3390/cancers14041072.
3
Comparison of Indexes to Measure Comorbidity Burden and Predict All-Cause Mortality in Rheumatoid Arthritis.
类风湿关节炎中衡量合并症负担及预测全因死亡率的指标比较
J Clin Med. 2021 Nov 22;10(22):5460. doi: 10.3390/jcm10225460.
4
Prediction of Other-Cause Mortality in Older Patients with Breast Cancer Using Comorbidity.利用合并症预测老年乳腺癌患者的其他原因死亡率
Cancers (Basel). 2021 Apr 1;13(7):1627. doi: 10.3390/cancers13071627.
5
Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data.验证国际疾病分类第 10 版编码在美国医疗保健索赔数据中对 Charlson 共病指数的适应性。
Pharmacoepidemiol Drug Saf. 2021 May;30(5):582-593. doi: 10.1002/pds.5204. Epub 2021 Mar 4.
6
Do morbidity measures predict the decline of activities of daily living and instrumental activities of daily living amongst older inpatients? A systematic review.患病指标能否预测老年住院患者日常生活活动和工具性日常生活活动的下降?系统评价。
Int J Clin Pract. 2021 Apr;75(4):e13838. doi: 10.1111/ijcp.13838. Epub 2020 Dec 14.
7
Reliability of comorbidity scores derived from administrative data in the tertiary hospital intensive care setting: a cross-sectional study.三级医院重症监护环境下源自管理数据的共病评分的可靠性:一项横断面研究。
BMJ Health Care Inform. 2019 Apr;26(1). doi: 10.1136/bmjhci-2019-000016.
8
Comorbidity Index as a Predictor of Mortality in Pediatric Patients With Solid Tumors.合并症指数作为实体瘤儿科患者死亡率的预测指标
Front Pediatr. 2019 Mar 1;7:48. doi: 10.3389/fped.2019.00048. eCollection 2019.
9
Comorbidity index in central cancer registries: the value of hospital discharge data.中央癌症登记处的合并症指数:医院出院数据的价值。
Clin Epidemiol. 2017 Nov 20;9:601-609. doi: 10.2147/CLEP.S146395. eCollection 2017.
10
Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities.基于人群的行政健康数据用于评估癌症非相关合并症的可重复性、可靠性和有效性。
PLoS One. 2017 Mar 6;12(3):e0172814. doi: 10.1371/journal.pone.0172814. eCollection 2017.